SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-241070
Filing Date
2020-09-08
Accepted
2020-09-08 16:46:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 35111
2 GRAPHIC g938924g0908093735738.jpg GRAPHIC 2532
  Complete submission text file 0001193125-20-241070.txt   39635
Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)